Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001547522-17-000040)

Filing Details

Accession Number:: 0001547522-17-000040
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-15 14:43:16
Reporting Period:: 2017-03-13

Filing Date:: 2017-03-15
Accepted Time:: 2017-03-15 14:43:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
811641	Immucell Corp	ICCC	In Vitro & In Vivo Diagnostic Substances (2835)	010382980

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384044	Scott David Tomsche	C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.10 Per Share	Acquisiton	2017-03-13	490	$5.40	71,279	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2017-03-13	313	$5.45	71,592	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2017-03-14	150	$5.46	71,742	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2017-03-14	658	$5.45	72,400	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2017-03-14	389	$5.41	72,789	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

(1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.